$2800 | Single User
$5600 | Enterprise License

Global Biosimilars Market Research Report Forecast 2017 to 2022 [Report Updated: 23-10-2017]

Published by S&P Consulting: 23 Oct 2017 | 146331 | In Stock

Introduction

Delivery of the Report will take 2-3 working days once order is placed.

The Global Biosimilars Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

Key market segments and sub-segments

Evolving market trends and dynamics

Changing supply and demand scenarios

Quantifying market opportunities through market sizing and market forecasting

Tracking current trends/opportunities/challenges

Competitive insights

Opportunity mapping in terms of technological breakthroughs

Global Biosimilars Market: Regional Segment Analysis

North America

Europe

China

Japan

Southeast Asia

India

The Major players reported in the market include:

Sandoz International

Hospira

Teva Pharmaceutical

Dr. Reddy’s Laboratories

Biocon

Mylan

Amgen

Celltrion

Roche Diagnostics

...

Global Biosimilars Market: Product Segment Analysis

Type 1

Type 2

Type 3


Global Biosimilars Market: Application Segment Analysis

Application 1

Application 2

Application 3

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Table of Contents
for Global Biosimilars Market Research Report Forecast 2017 to 2022 [Report Updated: 23-10-2017]

  • Global Biosimilars Market Research Report Forecast 2017-2022

    Chapter 1 Biosimilars Market Overview

    1.1 Product Overview and Scope of Biosimilars

    1.2 Biosimilars Market Segmentation by Type

    1.2.1 Global Production Market Share of Biosimilars by Type in 2016

    1.2.1 Type 1

    1.2.2 Type 2

    1.2.3 Type 3

    1.3 Biosimilars Market Segmentation by Application

    1.3.1 Biosimilars Consumption Market Share by Application in 2016

    1.3.2 Application 1

    1.3.3 Application 2

    1.3.4 Application 3

    1.4 Biosimilars Market Segmentation by Regions

    1.4.1 North America

    1.4.2 China

    1.4.3 Europe

    1.4.4 Southeast Asia

    1.4.5 Japan

    1.4.6 India

    1.5 Global Market Size (Value) of Biosimilars (2012-2022)

    Chapter 2 Global Economic Impact on Biosimilars Industry

    2.1 Global Macroeconomic Environment Analysis

    2.1.1 Global Macroeconomic Analysis

    2.1.2 Global Macroeconomic Environment Development Trend

    2.2 Global Macroeconomic Environment Analysis by Regions

    Chapter 3 Global Biosimilars Market Competition by Manufacturers

    3.1 Global Biosimilars Production and Share by Manufacturers (2015 and 2016)

    3.2 Global Biosimilars Revenue and Share by Manufacturers (2015 and 2016)

    3.3 Global Biosimilars Average Price by Manufacturers (2015 and 2016)

    3.4 Manufacturers Biosimilars Manufacturing Base Distribution, Production Area and Product Type

    3.5 Biosimilars Market Competitive Situation and Trends

    3.5.1 Biosimilars Market Concentration Rate

    3.5.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers

    3.5.3 Mergers & Acquisitions, Expansion

    Chapter 4 Global Biosimilars Production, Revenue (Value) by Region (2012-2017)

    4.1 Global Biosimilars Production by Region (2012-2017)

    4.2 Global Biosimilars Production Market Share by Region (2012-2017)

    4.3 Global Biosimilars Revenue (Value) and Market Share by Region (2012-2017)

    4.4 Global Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

    4.5 North America Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

    4.6 Europe Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

    4.7 China Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

    4.8 Japan Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

    4.9 Southeast Asia Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

    4.10 India Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

    Chapter 5 Global Biosimilars Supply (Production), Consumption, Export, Import by Regions (2012-2017)

    5.1 Global Biosimilars Consumption by Regions (2012-2017)

    5.2 North America Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)

    5.3 Europe Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)

    5.4 China Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)

    5.5 Japan Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)

    5.6 Southeast Asia Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)

    5.7 India Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)

    Chapter 6 Global Biosimilars Production, Revenue (Value), Price Trend by Type

    6.1 Global Biosimilars Production and Market Share by Type (2012-2017)

    6.2 Global Biosimilars Revenue and Market Share by Type (2012-2017)

    6.3 Global Biosimilars Price by Type (2012-2017)

    6.4 Global Biosimilars Production Growth by Type (2012-2017)

    Chapter 7 Global Biosimilars Market Analysis by Application

    7.1 Global Biosimilars Consumption and Market Share by Application (2012-2017)

    7.2 Global Biosimilars Consumption Growth Rate by Application (2012-2017)

    7.3 Market Drivers and Opportunities

    7.3.1 Potential Applications

    7.3.2 Emerging Markets/Countries

    Chapter 8 Global Biosimilars Manufacturers Analysis

    8.1 Sandoz International

    8.1.1 Company Basic Information, Manufacturing Base and Competitors

    8.1.2 Product Type, Application and Specification

    8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.1.4 Business Overview

    8.2 Hospira

    8.2.1 Company Basic Information, Manufacturing Base and Competitors

    8.2.2 Product Type, Application and Specification

    8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.2.4 Business Overview

    8.3 Teva Pharmaceutical

    8.3.1 Company Basic Information, Manufacturing Base and Competitors

    8.3.2 Product Type, Application and Specification

    8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.3.4 Business Overview

    8.4 Dr. Reddy’s Laboratories

    8.4.1 Company Basic Information, Manufacturing Base and Competitors

    8.4.2 Product Type, Application and Specification

    8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.4.4 Business Overview

    8.5 Biocon

    8.5.1 Company Basic Information, Manufacturing Base and Competitors

    8.5.2 Product Type, Application and Specification

    8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.5.4 Business Overview

    8.6 Mylan

    8.6.1 Company Basic Information, Manufacturing Base and Competitors

    8.6.2 Product Type, Application and Specification

    8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.6.4 Business Overview

    8.7 Amgen

    8.7.1 Company Basic Information, Manufacturing Base and Competitors

    8.7.2 Product Type, Application and Specification

    8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.7.4 Business Overview

    8.8 Celltrion

    8.8.1 Company Basic Information, Manufacturing Base and Competitors

    8.8.2 Product Type, Application and Specification

    8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.8.4 Business Overview

    8.9 Roche Diagnostics

    8.9.1 Company Basic Information, Manufacturing Base and Competitors

    8.9.2 Product Type, Application and Specification

    8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)

    8.9.4 Business Overview

    Chapter 9 Biosimilars Manufacturing Cost Analysis

    9.1 Biosimilars Key Raw Materials Analysis

    9.1.1 Key Raw Materials

    9.1.2 Price Trend of Key Raw Materials

    9.1.3 Key Suppliers of Raw Materials

    9.1.4 Market Concentration Rate of Raw Materials

    9.2 Proportion of Manufacturing Cost Structure

    9.2.1 Raw Materials

    9.2.2 Labor Cost

    9.2.3 Manufacturing Expenses

    9.3 Manufacturing Process Analysis of Biosimilars

    Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers

    10.1 Biosimilars Industrial Chain Analysis

    10.2 Upstream Raw Materials Sourcing

    10.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2016

    10.4 Downstream Buyers

    Chapter 11 Marketing Strategy Analysis, Distributors/Traders

    11.1 Marketing Channel

    11.1.1 Direct Marketing

    11.1.2 Indirect Marketing

    11.1.3 Marketing Channel Development Trend

    11.2 Market Positioning

    11.2.1 Pricing Strategy

    11.2.2 Brand Strategy

    11.2.3 Target Client

    11.3 Distributors/Traders List

    Chapter 12 Market Effect Factors Analysis

    12.1 Technology Progress/Risk

    12.1.1 Substitutes Threat

    12.1.2 Technology Progress in Related Industry

    12.2 Consumer Needs/Customer Preference Change

    12.3 Economic/Political Environmental Change

    Chapter 13 Global Biosimilars Market Forecast (2017-2022)

    13.1 Global Biosimilars Production, Revenue Forecast (2017-2022)

    13.2 Global Biosimilars Production, Consumption Forecast by Regions (2017-2022)

    13.3 Global Biosimilars Production Forecast by Type (2017-2022)

    13.4 Global Biosimilars Consumption Forecast by Application (2017-2022)

    13.5 Biosimilars Price Forecast (2017-2022)

    Chapter 14 Appendix

List Of Tables
in Global Biosimilars Market Research Report Forecast 2017 to 2022 [Report Updated: 23-10-2017]

Figure Picture of Biosimilars

Figure Global Production Market Share of Biosimilars by Type in 2016

Table Biosimilars Consumption Market Share by Application in 2016

Figure North America Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Biosimilars Revenue (Million UDS) and Growth Rate (2012-2022)

Table Global Biosimilars Capacity of Key Manufacturers (2015 and 2016)

Table Global Biosimilars Capacity Market Share by Manufacturers (2015 and 2016)

Figure Global Biosimilars Capacity of Key Manufacturers in 2015

Figure Global Biosimilars Capacity of Key Manufacturers in 2016

Table Global Biosimilars Production of Key Manufacturers (2015 and 2016)

Table Global Biosimilars Production Share by Manufacturers (2015 and 2016)

Figure 2015 Biosimilars Production Share by Manufacturers

Figure 2016 Biosimilars Production Share by Manufacturers

Table Global Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Biosimilars Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Biosimilars Revenue Share by Manufacturers

Table 2016 Global Biosimilars Revenue Share by Manufacturers

Table Global Market Biosimilars Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Biosimilars Average Price of Key Manufacturers in 2016

Table Manufacturers Biosimilars Manufacturing Base Distribution and Sales Area

Table Manufacturers Biosimilars Product Type

Figure Biosimilars Market Share of Top 3 Manufacturers

Figure Biosimilars Market Share of Top 5 Manufacturers

Table Global Biosimilars Capacity by Regions (2012-2017)

Figure Global Biosimilars Capacity Market Share by Regions (2012-2017)

Figure Global Biosimilars Capacity Market Share by Regions (2012-2017)

Figure 2015 Global Biosimilars Capacity Market Share by Regions

Table Global Biosimilars Production by Regions (2012-2017)

Figure Global Biosimilars Production and Market Share by Regions (2012-2017)

Figure Global Biosimilars Production Market Share by Regions (2012-2017)

Figure 2015 Global Biosimilars Production Market Share by Regions

Table Global Biosimilars Revenue by Regions (2012-2017)

Table Global Biosimilars Revenue Market Share by Regions (2012-2017)

Table 2015 Global Biosimilars Revenue Market Share by Regions

Table Global Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table North America Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Europe Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table China Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Japan Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Southeast Asia Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table India Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Global Biosimilars Consumption Market by Regions (2012-2017)

Table Global Biosimilars Consumption Market Share by Regions (2012-2017)

Figure Global Biosimilars Consumption Market Share by Regions (2012-2017)

Figure 2015 Global Biosimilars Consumption Market Share by Regions

Table North America Biosimilars Production, Consumption, Import & Export (2012-2017)

Table Europe Biosimilars Production, Consumption, Import & Export (2012-2017)

Table China Biosimilars Production, Consumption, Import & Export (2012-2017)

Table Japan Biosimilars Production, Consumption, Import & Export (2012-2017)

Table Southeast Asia Biosimilars Production, Consumption, Import & Export (2012-2017)

Table India Biosimilars Production, Consumption, Import & Export (2012-2017)

Table Global Biosimilars Production by Type (2012-2017)

Table Global Biosimilars Production Share by Type (2012-2017)

Figure Production Market Share of Biosimilars by Type (2012-2017)

Figure 2015 Production Market Share of Biosimilars by Type

Table Global Biosimilars Revenue by Type (2012-2017)

Table Global Biosimilars Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Biosimilars by Type (2012-2017)

Figure 2015 Revenue Market Share of Biosimilars by Type

Table Global Biosimilars Price by Type (2012-2017)

Figure Global Biosimilars Production Growth by Type (2012-2017)

Table Global Biosimilars Consumption by Application (2012-2017)

Table Global Biosimilars Consumption Market Share by Application (2012-2017)

Figure Global Biosimilars Consumption Market Share by Application in 2015

Table Global Biosimilars Consumption Growth Rate by Application (2012-2017)

Figure Global Biosimilars Consumption Growth Rate by Application (2012-2017)

Table Sandoz International Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Sandoz International Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Sandoz International Biosimilars Market Share (2012-2017)

Table Hospira Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Hospira Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Hospira Biosimilars Market Share (2012-2017)

Table Teva Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Teva Pharmaceutical Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Teva Pharmaceutical Biosimilars Market Share (2012-2017)

Table Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Dr. Reddy’s Laboratories Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Dr. Reddy’s Laboratories Biosimilars Market Share (2012-2017)

Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Biocon Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Biocon Biosimilars Market Share (2012-2017)

Table Mylan Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Mylan Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Mylan Biosimilars Market Share (2012-2017)

Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Amgen Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Amgen Biosimilars Market Share (2012-2017)

Table Celltrion Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Celltrion Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Celltrion Biosimilars Market Share (2012-2017)

Table Roche Diagnostics Basic Information, Manufacturing Base, Production Area and Its Competitors

Table Roche Diagnostics Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

Table Roche Diagnostics Biosimilars Market Share (2012-2017)


Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biosimilars

Figure Manufacturing Process Analysis of Biosimilars

Figure Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biosimilars Major Manufacturers in 2016

Table Major Buyers of Biosimilars

Table Distributors/Traders List

Figure Global Biosimilars Production and Growth Rate Forecast (2017-2022)

Figure Global Biosimilars Revenue and Growth Rate Forecast (2017-2022)

Table Global Biosimilars Production Forecast by Regions (2017-2022)

Table Global Biosimilars Consumption Forecast by Regions (2017-2022)

Table Global Biosimilars Production Forecast by Type (2017-2022)

Table Global Biosimilars Consumption Forecast by Application (2017-2022)

Additional Details

Publisher

S&P Consulting

Publisher Information

S&P Consulting, with the full name of “Beijing S&P Huaxin Global Investment Consulting Co., Ltd.", is a company with years of consulting service experience. The company has become the leader in investment consulting and market research in China, and passed the certification of ISO9001: 2008 international quality management system. Currently, the company has more than 1,500 experts with expertise covering various fields.



With nearly a decade of experience in consulting services, S&P Consulting now has four business modules including investment consulting, industry research, market research and IPO consulting of enterprises to be listed, and providefeasibility study report,, project application report, roject approval report, energy-saving assessment, social stability risk assessment, project implementation plan, funding application reports, business financing plans, project proposals, investment opportunities research, industrial park planning, industry research, competitor research, market entry studies, consumer research, IPO market segments studyand other consulting services.



Till the end of 2015, the company has completed more than 7,000 cases consulting projects of various types and has become the designated supplier of many Global Top 500 companies including Samsung, SIEMENS, LG, Microsoft, Sony, Panasonic, Dow, Shell, Accenture, CNPC, etc.

Reference

146331 |

Number of Pages

100

Report Format

PDF

S&P Consulting Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Biosimilars in Oncology: Update Bulletin [Feb 2016]
Introduction new KOL insights on the latest events that have the potential to shape the oncology bio...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Biosimilars in Oncology: KOL Insight
IntroductionWill physicians ever adopt Biosimilars in Oncology?Sceptical, survival focussed oncologi...
01 Jan 2016 by FirstWord Pharma USD $7,900 More Info
Biosimilars: European Payer Perspectives (2016)
IntroductionWhat’s driving the uptake of biosimilars in Europe and what still needs to be done?The E...
01 Jan 2016 by FirstWord Pharma USD $2,195 More Info
Biosimilars: Regulatory Outlook
IntroductionBiosimilars offer a chance to improve access to, and reduce spending on, life-saving bio...
01 Nov 2015 by FirstWord Pharma USD $2,195 More Info
The Future of Biosimilars 2015
IntroductionThe Future of Biosimilars 2015 offers expert insight and opinion on the key issues facin...
01 Jun 2015 by FirstWord Pharma USD $2,195 More Info
Biosimilars: US Payer Perspectives
IntroductionBiosimilars: US Payer Perspectives pulls back the curtain on the US biologics market and...
01 Apr 2015 by FirstWord Pharma USD $2,195 More Info
Biosimilars: European Payer Perspectives
IntroductionCost is king when it comes to European biosimilars. One issue unites European healthca...
06 Jan 2015 by FirstWord Pharma USD $2,195 More Info
The Future of Biosimilars: mapping critical uncertainties and the impact of future events
IntroductionThe Future of Biosimilars: Mapping Critical Uncertainties and the Impact of Future Event...
05 May 2014 by FirstWord Pharma USD $1,950 More Info
Commercialisation of Biosimilars: strategies for market penetration
IntroductionTimes, they are a-changin’—at least for the American biological product market. With fiv...
01 Nov 2013 by FirstWord Pharma USD $695 More Info
Biosimilars in Emerging Markets
IntroductionWhat are the implications for regulators, biosimilar companies and branded manufacturers...
01 Mar 2013 by FirstWord Pharma USD $665 More Info

This report is published by S&P Consulting

S&P Consulting, with the full name of “Beijing S&P Huaxin Global Investment Consulting Co., Ltd.", is a company with years of consulting service experience. The company has become the leader in investment consulting and market research in China, and passed the certification of ISO9001: 2008 international quality management system. Currently, the company has more than 1,500 experts with expertise covering various fields.

With nearly a decade of experience in consulting services, S&P Consulting now has four business modules including investment consulting, industry research, market research and IPO consulting of enterprises to be listed, and providefeasibility study report,, project application report, roject approval report, energy-saving assessment, social stability risk assessment, project implementation plan, funding application reports, business financing plans, project proposals, investment opportunities research, industrial park planning, industry research, competitor research, market entry studies, consumer research, IPO market segments studyand other consulting services.

Till the end of 2015, the company has completed more than 7,000 cases consulting projects of various types and has become the designated supplier of many Global Top 500 companies including Samsung, SIEMENS, LG, Microsoft, Sony, Panasonic, Dow, Shell, Accenture, CNPC, etc.

Download Free Report Summary PDF

Global Biosimilars Market Research Report Forecast 2017 to 2022 [Report Updated: 23-10-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data